Avandia, which contains the chemical ingredient Rosiglitazone, is a popular drug used in diabetes; its fate to remain on pharmacy shelves is currently being debated as there are controversial studies linking Avandia with an increased risk of heart attacks.  The U.S. Food and Drug Administration are considering to ban Avandia from the market due to safety concerns.  It is not surprising to know that the pharmaceutical company GlaxoSmithKline reports that the drug is safe; who can blame them given the fact that Avandia is their third best selling drug in 2006, with revenue of $ 2.2 billion.   However, when reports surfaced the following year that Avandia was linked to heart attacks, the company’s earnings were cut in half by the end of 2008.  Other medications that contain Rosiglitazone are marketed under the names Avandamet and Avandaryl.